These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1797500)

  • 1. Successful treatment of unusual case of brittle diabetes with sulfated beef insulin.
    Davidson MB; Kumar D; Smith W
    Diabetes Care; 1991 Nov; 14(11):1109-10. PubMed ID: 1797500
    [No Abstract]   [Full Text] [Related]  

  • 2. Mixing insulin lispro and ultralente insulin.
    Bastyr EJ; Holcombe JH; Anderson JH; Clore JN
    Diabetes Care; 1997 Jun; 20(6):1047-8. PubMed ID: 9167130
    [No Abstract]   [Full Text] [Related]  

  • 3. Selecting an insulin program for type 1 diabetes.
    Scheiner G
    Diabetes Self Manag; 2003; 20(5):54-6, 58. PubMed ID: 14679953
    [No Abstract]   [Full Text] [Related]  

  • 4. Long term use of intravenous insulin because of failure of subcutaneous insulin treatment.
    Diaz-Pereda L; Yang TI; Knowles HC
    Trans Am Clin Climatol Assoc; 1979; 90():102-8. PubMed ID: 516224
    [No Abstract]   [Full Text] [Related]  

  • 5. Type I diabetes. Control with individualized insulin regimens.
    Spencer M
    Postgrad Med; 1989 Mar; 85(4):201-9. PubMed ID: 2648355
    [No Abstract]   [Full Text] [Related]  

  • 6. Generalized allergy due to zinc and protamine in insulin preparation treated with insulin pump.
    Gin H; Aubertin J
    Diabetes Care; 1987; 10(6):789-90. PubMed ID: 3322735
    [No Abstract]   [Full Text] [Related]  

  • 7. [Flexible intensive insulin therapy: a change in mentalities].
    Penfornis A; Chabroux S; Grimaldi A
    Rev Med Interne; 2008 Nov; 29(11):857-60. PubMed ID: 18387717
    [No Abstract]   [Full Text] [Related]  

  • 8. Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen.
    Mohn A; Strang S; Wernicke-Panten K; Lang AM; Edge JA; Dunger DB
    Diabetes Care; 2000 Apr; 23(4):557-9. PubMed ID: 10857953
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative evaluation of the effectiveness of insulin preparations "Lente GP" and "Insulong" in type 1 diabetes mellitus].
    Kudriakova SV; Belovanova IM; Romanovskaia GA; Kasymov UA
    Sov Med; 1991; (9):75-7. PubMed ID: 1798933
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.
    Rassam AG; Zeise TM; Burge MR; Schade DS
    Diabetes Care; 1999 Jan; 22(1):133-6. PubMed ID: 10333914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-acting basal insulin].
    Meißner T
    MMW Fortschr Med; 2015 Jul; 157(13):82. PubMed ID: 26206056
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term use of intramuscular insulin therapy in a type I diabetic patient with subcutaneous insulin resistance.
    Brossard JH; Havrankova J; Rioux D; Bertrand S; D'Amour P
    Diabet Med; 1993 Mar; 10(2):174-6. PubMed ID: 8458196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human insulin and insulin pumps.
    Shuman CR
    Clin Ther; 1984; 6(4):380-7. PubMed ID: 6380721
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological and metabolic responses of patients with history of antibody-induced beef insulin resistance to treatment with beef, pork, human, and sulfated beef insulin.
    Davidson JK; Fineberg SE; De Meyts P; Fineberg NS; Galloway JA
    Diabetes Care; 1992 May; 15(5):702-4. PubMed ID: 1516491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixtures of soluble insulin with zinc-suspension or protamine insulin have different effect on blood glucose and free insulin levels in insulin dependent diabetes.
    Lunetta M; Di Mauro M; Mughini L
    Diabete Metab; 1988; 14(3):315-6. PubMed ID: 3044867
    [No Abstract]   [Full Text] [Related]  

  • 16. Human ultralente insulin.
    Holman RR; Steemson J; Darling P; Reeves WG; Turner RC
    Br Med J (Clin Res Ed); 1984 Mar; 288(6418):665-8. PubMed ID: 6421424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New freedoms in insulin therapy].
    MMW Fortschr Med; 2015 Feb; 157(3):64. PubMed ID: 25743674
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimizing glycemic control with insulin glargine.
    Williams JB
    Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
    [No Abstract]   [Full Text] [Related]  

  • 19. [New flexibility in diabetes therapy].
    Danne T
    MMW Fortschr Med; 2015 Feb; 157(3):65. PubMed ID: 25743681
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of beef ultralente for basal insulin delivery: plasma insulin concentrations after chronic ultralente administration in patients with IDDM.
    Rizza RA; O'Brien PC; Service FJ
    Diabetes Care; 1986; 9(2):120-3. PubMed ID: 3698778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.